SHARE-BASED PAYMENTS - Options, Rights and RSUs Granted as Share-Based Payments (Details)
|
12 Months Ended |
|
Jun. 30, 2026
AUD ($)
shares
$ / shares
|
Jun. 30, 2025
AUD ($)
shares
$ / shares
|
Jun. 30, 2024
AUD ($)
shares
$ / shares
|
| Options, rights and restricted stock units granted as share-based payments [Abstract] |
|
|
|
| Options, Number (in shares) | shares |
4,086,871
|
2,679,746
|
0
|
| Options, Exercise Price (in dollars per share) |
$ 18.40
|
$ 6.46
|
$ 0
|
| Vesting Hurdle (30-day VWAP) (weighted average) (in dollars per share) |
$ 18.00
|
$ 6.02
|
$ 3.93
|
| Performance Rights |
|
|
|
| Options, rights and restricted stock units granted as share-based payments [Abstract] |
|
|
|
| Number (in shares) | shares |
769,077
|
5,288,409
|
4,021,000
|
| Performance Rights, Series 1 |
|
|
|
| Options, rights and restricted stock units granted as share-based payments [Abstract] |
|
|
|
| Number (in shares) | shares |
45,000
|
445,000
|
|
| Exercise Price (in dollars per share) |
$ 0
|
$ 0
|
|
| Vesting Hurdle (30-day VWAP) (weighted average) (in dollars per share) |
|
$ 4.00
|
|
| Fair Value | $ |
$ 5.99
|
$ 2.98
|
|
| Performance Rights, Series 2 |
|
|
|
| Options, rights and restricted stock units granted as share-based payments [Abstract] |
|
|
|
| Number (in shares) | shares |
|
435,000
|
21,000
|
| Exercise Price (in dollars per share) |
|
$ 0
|
$ 0
|
| Vesting Hurdle (30-day VWAP) (weighted average) (in dollars per share) |
|
$ 3.00
|
$ 0
|
| Fair Value | $ |
|
$ 3.12
|
$ 1.10
|
| Performance Rights, Series 3 |
|
|
|
| Options, rights and restricted stock units granted as share-based payments [Abstract] |
|
|
|
| Number (in shares) | shares |
|
585,000
|
10,000
|
| Exercise Price (in dollars per share) |
|
$ 0
|
$ 0
|
| Vesting Hurdle (30-day VWAP) (weighted average) (in dollars per share) |
|
$ 4.00
|
$ 0
|
| Fair Value | $ |
|
$ 2.53
|
$ 1.10
|
| Performance Rights, Series 4 |
|
|
|
| Options, rights and restricted stock units granted as share-based payments [Abstract] |
|
|
|
| Number (in shares) | shares |
|
30,000
|
10,000
|
| Exercise Price (in dollars per share) |
|
$ 0
|
$ 0
|
| Vesting Hurdle (30-day VWAP) (weighted average) (in dollars per share) |
|
$ 0
|
$ 0
|
| Fair Value | $ |
|
$ 3.40
|
$ 1.10
|
| Performance Rights, Series 5 |
|
|
|
| Options, rights and restricted stock units granted as share-based payments [Abstract] |
|
|
|
| Number (in shares) | shares |
64,000
|
200,000
|
200,000
|
| Exercise Price (in dollars per share) |
$ 0
|
$ 0
|
$ 0
|
| Vesting Hurdle (30-day VWAP) (weighted average) (in dollars per share) |
$ 0
|
$ 0
|
$ 3.00
|
| Fair Value | $ |
$ 5.03
|
$ 3.40
|
$ 0.79
|
| Performance Rights, Series 6 |
|
|
|
| Options, rights and restricted stock units granted as share-based payments [Abstract] |
|
|
|
| Number (in shares) | shares |
|
|
300,000
|
| Exercise Price (in dollars per share) |
|
|
$ 0
|
| Vesting Hurdle (30-day VWAP) (weighted average) (in dollars per share) |
|
|
$ 4.00
|
| Fair Value | $ |
|
|
$ 0.63
|
| Performance Rights, Series 7 |
|
|
|
| Options, rights and restricted stock units granted as share-based payments [Abstract] |
|
|
|
| Number (in shares) | shares |
|
|
3,330,000
|
| Exercise Price (in dollars per share) |
|
|
$ 0
|
| Vesting Hurdle (30-day VWAP) (weighted average) (in dollars per share) |
|
|
$ 4.00
|
| Fair Value | $ |
|
|
$ 1.01
|
| Performance Rights, Series 8 |
|
|
|
| Options, rights and restricted stock units granted as share-based payments [Abstract] |
|
|
|
| Number (in shares) | shares |
|
120,000
|
|
| Exercise Price (in dollars per share) |
|
$ 0
|
|
| Vesting Hurdle (30-day VWAP) (weighted average) (in dollars per share) |
|
$ 0
|
|
| Fair Value | $ |
|
$ 4.60
|
|
| Performance Rights, Series 10 |
|
|
|
| Options, rights and restricted stock units granted as share-based payments [Abstract] |
|
|
|
| Number (in shares) | shares |
226,047
|
|
|
| Exercise Price (in dollars per share) |
$ 0
|
|
|
| Vesting Hurdle (30-day VWAP) (weighted average) (in dollars per share) |
$ 18.00
|
|
|
| Fair Value | $ |
$ 4.47
|
|
|
| Performance Rights, Series 13 |
|
|
|
| Options, rights and restricted stock units granted as share-based payments [Abstract] |
|
|
|
| Number (in shares) | shares |
|
|
75,000
|
| Exercise Price (in dollars per share) |
|
|
$ 0
|
| Vesting Hurdle (30-day VWAP) (weighted average) (in dollars per share) |
|
|
$ 3.00
|
| Fair Value | $ |
|
|
$ 1.61
|
| Performance Rights, Series 14 |
|
|
|
| Options, rights and restricted stock units granted as share-based payments [Abstract] |
|
|
|
| Number (in shares) | shares |
|
|
75,000
|
| Exercise Price (in dollars per share) |
|
|
$ 0
|
| Vesting Hurdle (30-day VWAP) (weighted average) (in dollars per share) |
|
|
$ 4.00
|
| Fair Value | $ |
|
|
$ 1.32
|
| Performance Rights, Series 16 |
|
|
|
| Options, rights and restricted stock units granted as share-based payments [Abstract] |
|
|
|
| Number (in shares) | shares |
434,030
|
|
|
| Exercise Price (in dollars per share) |
$ 0
|
|
|
| Vesting Hurdle (30-day VWAP) (weighted average) (in dollars per share) |
$ 18.00
|
|
|
| Fair Value | $ |
$ 1.72
|
|
|
| Performance Rights, Series 18 |
|
|
|
| Options, rights and restricted stock units granted as share-based payments [Abstract] |
|
|
|
| Number (in shares) | shares |
|
415,695
|
|
| Exercise Price (in dollars per share) |
|
$ 0
|
|
| Vesting Hurdle (30-day VWAP) (weighted average) (in dollars per share) |
|
$ 6.00
|
|
| Fair Value | $ |
|
$ 2.76
|
|
| Performance Rights, Series 19 |
|
|
|
| Options, rights and restricted stock units granted as share-based payments [Abstract] |
|
|
|
| Number (in shares) | shares |
|
415,695
|
|
| Exercise Price (in dollars per share) |
|
$ 0
|
|
| Vesting Hurdle (30-day VWAP) (weighted average) (in dollars per share) |
|
$ 7.00
|
|
| Fair Value | $ |
|
$ 2.68
|
|
| Performance Rights, Series 20 |
|
|
|
| Options, rights and restricted stock units granted as share-based payments [Abstract] |
|
|
|
| Number (in shares) | shares |
|
415,695
|
|
| Exercise Price (in dollars per share) |
|
$ 0
|
|
| Vesting Hurdle (30-day VWAP) (weighted average) (in dollars per share) |
|
$ 8.00
|
|
| Fair Value | $ |
|
$ 2.60
|
|
| Performance Rights, Series 32 |
|
|
|
| Options, rights and restricted stock units granted as share-based payments [Abstract] |
|
|
|
| Number (in shares) | shares |
|
742,108
|
|
| Exercise Price (in dollars per share) |
|
$ 0
|
|
| Vesting Hurdle (30-day VWAP) (weighted average) (in dollars per share) |
|
$ 6.00
|
|
| Fair Value | $ |
|
$ 4.48
|
|
| Performance Rights, Series 33 |
|
|
|
| Options, rights and restricted stock units granted as share-based payments [Abstract] |
|
|
|
| Number (in shares) | shares |
|
742,108
|
|
| Exercise Price (in dollars per share) |
|
$ 0
|
|
| Vesting Hurdle (30-day VWAP) (weighted average) (in dollars per share) |
|
$ 7.00
|
|
| Fair Value | $ |
|
$ 4.38
|
|
| Performance Rights, Series 34 |
|
|
|
| Options, rights and restricted stock units granted as share-based payments [Abstract] |
|
|
|
| Number (in shares) | shares |
|
742,108
|
|
| Exercise Price (in dollars per share) |
|
$ 0
|
|
| Vesting Hurdle (30-day VWAP) (weighted average) (in dollars per share) |
|
$ 8.00
|
|
| Fair Value | $ |
|
$ 4.29
|
|
| Restricted Stock Units |
|
|
|
| Options, rights and restricted stock units granted as share-based payments [Abstract] |
|
|
|
| Number (in shares) | shares |
853,979
|
2,220,020
|
3,894,124
|
| Exercise Price (in dollars per share) |
$ 6.53
|
$ 3.99
|
$ 2.18
|
| Restricted Share Units, Series 2 |
|
|
|
| Options, rights and restricted stock units granted as share-based payments [Abstract] |
|
|
|
| Number (in shares) | shares |
118,875
|
|
|
| Exercise Price (in dollars per share) |
$ 0
|
|
|
| Vesting Hurdle (30-day VWAP) (weighted average) (in dollars per share) |
$ 0
|
|
|
| Fair Value | $ |
$ 5.11
|
|
|
| Restricted Share Units, Series 3 |
|
|
|
| Options, rights and restricted stock units granted as share-based payments [Abstract] |
|
|
|
| Number (in shares) | shares |
12,000
|
|
|
| Exercise Price (in dollars per share) |
$ 0
|
|
|
| Vesting Hurdle (30-day VWAP) (weighted average) (in dollars per share) |
$ 0
|
|
|
| Fair Value | $ |
$ 5.02
|
|
|
| Restricted Share Units, Series 6 |
|
|
|
| Options, rights and restricted stock units granted as share-based payments [Abstract] |
|
|
|
| Number (in shares) | shares |
477,752
|
25,132
|
|
| Exercise Price (in dollars per share) |
$ 0
|
$ 0
|
|
| Vesting Hurdle (30-day VWAP) (weighted average) (in dollars per share) |
$ 0
|
$ 0
|
|
| Fair Value | $ |
$ 6.91
|
$ 3.40
|
|
| Restricted Share Units, Series 7 |
|
|
|
| Options, rights and restricted stock units granted as share-based payments [Abstract] |
|
|
|
| Number (in shares) | shares |
|
169,944
|
|
| Exercise Price (in dollars per share) |
|
$ 0
|
|
| Vesting Hurdle (30-day VWAP) (weighted average) (in dollars per share) |
|
$ 0
|
|
| Fair Value | $ |
|
$ 4.40
|
|
| Restricted Share Units, Series 9 |
|
|
|
| Options, rights and restricted stock units granted as share-based payments [Abstract] |
|
|
|
| Number (in shares) | shares |
|
42,486
|
|
| Exercise Price (in dollars per share) |
|
$ 0
|
|
| Vesting Hurdle (30-day VWAP) (weighted average) (in dollars per share) |
|
$ 0
|
|
| Fair Value | $ |
|
$ 3.37
|
|
| Restricted Share Units, Series 10 |
|
|
|
| Options, rights and restricted stock units granted as share-based payments [Abstract] |
|
|
|
| Number (in shares) | shares |
|
40,000
|
1,434,000
|
| Exercise Price (in dollars per share) |
|
$ 0
|
$ 0
|
| Vesting Hurdle (30-day VWAP) (weighted average) (in dollars per share) |
|
$ 0
|
$ 0
|
| Fair Value | $ |
|
$ 3.49
|
$ 2.27
|
| Restricted Share Units, Series 11 |
|
|
|
| Options, rights and restricted stock units granted as share-based payments [Abstract] |
|
|
|
| Number (in shares) | shares |
209,032
|
113,475
|
2,055,000
|
| Exercise Price (in dollars per share) |
$ 0
|
$ 0
|
$ 0
|
| Vesting Hurdle (30-day VWAP) (weighted average) (in dollars per share) |
$ 0
|
$ 0
|
$ 0
|
| Fair Value | $ |
$ 6.55
|
$ 3.40
|
$ 2.27
|
| Restricted Share Units, Series 12 |
|
|
|
| Options, rights and restricted stock units granted as share-based payments [Abstract] |
|
|
|
| Number (in shares) | shares |
20,820
|
56,738
|
405,124
|
| Exercise Price (in dollars per share) |
$ 0
|
$ 0
|
$ 0
|
| Vesting Hurdle (30-day VWAP) (weighted average) (in dollars per share) |
$ 0
|
$ 0
|
$ 0
|
| Fair Value | $ |
$ 6.55
|
$ 3.55
|
$ 1.42
|
| Restricted Share Units, Series 13 |
|
|
|
| Options, rights and restricted stock units granted as share-based payments [Abstract] |
|
|
|
| Number (in shares) | shares |
15,500
|
82,335
|
|
| Exercise Price (in dollars per share) |
$ 0
|
$ 0
|
|
| Vesting Hurdle (30-day VWAP) (weighted average) (in dollars per share) |
$ 0
|
$ 0
|
|
| Fair Value | $ |
$ 6.55
|
$ 3.55
|
|
| Restricted Share Units, Series 15 |
|
|
|
| Options, rights and restricted stock units granted as share-based payments [Abstract] |
|
|
|
| Number (in shares) | shares |
|
13,617
|
|
| Exercise Price (in dollars per share) |
|
$ 0
|
|
| Vesting Hurdle (30-day VWAP) (weighted average) (in dollars per share) |
|
$ 0
|
|
| Fair Value | $ |
|
$ 3.41
|
|
| Restricted Share Units, Series 16 |
|
|
|
| Options, rights and restricted stock units granted as share-based payments [Abstract] |
|
|
|
| Number (in shares) | shares |
|
8,511
|
|
| Exercise Price (in dollars per share) |
|
$ 0
|
|
| Vesting Hurdle (30-day VWAP) (weighted average) (in dollars per share) |
|
$ 0
|
|
| Fair Value | $ |
|
$ 3.17
|
|
| Restricted Share Units, Series 17 |
|
|
|
| Options, rights and restricted stock units granted as share-based payments [Abstract] |
|
|
|
| Number (in shares) | shares |
|
400,533
|
|
| Exercise Price (in dollars per share) |
|
$ 0
|
|
| Vesting Hurdle (30-day VWAP) (weighted average) (in dollars per share) |
|
$ 0
|
|
| Fair Value | $ |
|
$ 3.11
|
|
| Restricted Share Units, Series 21 |
|
|
|
| Options, rights and restricted stock units granted as share-based payments [Abstract] |
|
|
|
| Number (in shares) | shares |
|
48,227
|
|
| Exercise Price (in dollars per share) |
|
$ 0
|
|
| Vesting Hurdle (30-day VWAP) (weighted average) (in dollars per share) |
|
$ 0
|
|
| Fair Value | $ |
|
$ 3.20
|
|
| Restricted Share Units, Series 22 |
|
|
|
| Options, rights and restricted stock units granted as share-based payments [Abstract] |
|
|
|
| Number (in shares) | shares |
|
82,335
|
|
| Exercise Price (in dollars per share) |
|
$ 0
|
|
| Vesting Hurdle (30-day VWAP) (weighted average) (in dollars per share) |
|
$ 0
|
|
| Fair Value | $ |
|
$ 3.55
|
|
| Restricted Share Units, Series 24 |
|
|
|
| Options, rights and restricted stock units granted as share-based payments [Abstract] |
|
|
|
| Number (in shares) | shares |
|
24,823
|
|
| Exercise Price (in dollars per share) |
|
$ 0
|
|
| Vesting Hurdle (30-day VWAP) (weighted average) (in dollars per share) |
|
$ 0
|
|
| Fair Value | $ |
|
$ 3.58
|
|
| Restricted Share Units, Series 25 |
|
|
|
| Options, rights and restricted stock units granted as share-based payments [Abstract] |
|
|
|
| Number (in shares) | shares |
|
9,362
|
|
| Exercise Price (in dollars per share) |
|
$ 0
|
|
| Vesting Hurdle (30-day VWAP) (weighted average) (in dollars per share) |
|
$ 0
|
|
| Fair Value | $ |
|
$ 3.69
|
|
| Restricted Share Units, Series 26 |
|
|
|
| Options, rights and restricted stock units granted as share-based payments [Abstract] |
|
|
|
| Number (in shares) | shares |
|
26,326
|
|
| Exercise Price (in dollars per share) |
|
$ 0
|
|
| Vesting Hurdle (30-day VWAP) (weighted average) (in dollars per share) |
|
$ 0
|
|
| Fair Value | $ |
|
$ 3.69
|
|
| Restricted Share Units, Series 27 |
|
|
|
| Options, rights and restricted stock units granted as share-based payments [Abstract] |
|
|
|
| Number (in shares) | shares |
|
357,732
|
|
| Exercise Price (in dollars per share) |
|
$ 0
|
|
| Vesting Hurdle (30-day VWAP) (weighted average) (in dollars per share) |
|
$ 0
|
|
| Fair Value | $ |
|
$ 4.10
|
|
| Restricted Share Units, Series 29 |
|
|
|
| Options, rights and restricted stock units granted as share-based payments [Abstract] |
|
|
|
| Number (in shares) | shares |
|
3,404
|
|
| Exercise Price (in dollars per share) |
|
$ 0
|
|
| Vesting Hurdle (30-day VWAP) (weighted average) (in dollars per share) |
|
$ 0
|
|
| Fair Value | $ |
|
$ 4.10
|
|
| Restricted Share Units, Series 31 |
|
|
|
| Options, rights and restricted stock units granted as share-based payments [Abstract] |
|
|
|
| Number (in shares) | shares |
|
715,040
|
|
| Exercise Price (in dollars per share) |
|
$ 0
|
|
| Vesting Hurdle (30-day VWAP) (weighted average) (in dollars per share) |
|
$ 0
|
|
| Fair Value | $ |
|
$ 4.75
|
|
| Share Options, Series 7 |
|
|
|
| Options, rights and restricted stock units granted as share-based payments [Abstract] |
|
|
|
| Options, Number (in shares) | shares |
511,972
|
|
|
| Options, Exercise Price (in dollars per share) |
$ 11.00
|
|
|
| Vesting Hurdle (30-day VWAP) (weighted average) (in dollars per share) |
$ 0
|
|
|
| Options, Fair Value | $ |
$ 2.93
|
|
|
| Share Options, Series 8 |
|
|
|
| Options, rights and restricted stock units granted as share-based payments [Abstract] |
|
|
|
| Options, Number (in shares) | shares |
607,244
|
|
|
| Options, Exercise Price (in dollars per share) |
$ 22.00
|
|
|
| Vesting Hurdle (30-day VWAP) (weighted average) (in dollars per share) |
$ 0
|
|
|
| Options, Fair Value | $ |
$ 2.27
|
|
|
| Share Options, Series 9 |
|
|
|
| Options, rights and restricted stock units granted as share-based payments [Abstract] |
|
|
|
| Options, Number (in shares) | shares |
536,521
|
|
|
| Options, Exercise Price (in dollars per share) |
$ 18.00
|
|
|
| Vesting Hurdle (30-day VWAP) (weighted average) (in dollars per share) |
$ 0
|
|
|
| Options, Fair Value | $ |
$ 2.57
|
|
|
| Share Options, Series 14 |
|
|
|
| Options, rights and restricted stock units granted as share-based payments [Abstract] |
|
|
|
| Options, Number (in shares) | shares |
1,165,965
|
216,672
|
|
| Options, Exercise Price (in dollars per share) |
$ 22.00
|
$ 5.00
|
|
| Vesting Hurdle (30-day VWAP) (weighted average) (in dollars per share) |
$ 0
|
$ 0
|
|
| Options, Fair Value | $ |
$ 0.96
|
$ 1.87
|
|
| Share Options, Series 15 |
|
|
|
| Options, rights and restricted stock units granted as share-based payments [Abstract] |
|
|
|
| Options, Number (in shares) | shares |
1,030,169
|
|
|
| Options, Exercise Price (in dollars per share) |
$ 18.00
|
|
|
| Vesting Hurdle (30-day VWAP) (weighted average) (in dollars per share) |
$ 0
|
|
|
| Options, Fair Value | $ |
$ 1.11
|
|
|
| Share Options, Series 23 |
|
|
|
| Options, rights and restricted stock units granted as share-based payments [Abstract] |
|
|
|
| Options, Number (in shares) | shares |
|
216,672
|
|
| Options, Exercise Price (in dollars per share) |
|
$ 5.00
|
|
| Vesting Hurdle (30-day VWAP) (weighted average) (in dollars per share) |
|
$ 0
|
|
| Options, Fair Value | $ |
|
$ 1.86
|
|
| Share Options, Series 28 |
|
|
|
| Options, rights and restricted stock units granted as share-based payments [Abstract] |
|
|
|
| Options, Number (in shares) | shares |
|
941,402
|
|
| Options, Exercise Price (in dollars per share) |
|
$ 5.00
|
|
| Vesting Hurdle (30-day VWAP) (weighted average) (in dollars per share) |
|
$ 0
|
|
| Options, Fair Value | $ |
|
$ 2.26
|
|
| Share Options, Series 30 |
|
|
|
| Options, rights and restricted stock units granted as share-based payments [Abstract] |
|
|
|
| Options, Number (in shares) | shares |
235,000
|
1,305,000
|
|
| Options, Exercise Price (in dollars per share) |
$ 10.00
|
$ 8.00
|
|
| Vesting Hurdle (30-day VWAP) (weighted average) (in dollars per share) |
$ 0
|
$ 0
|
|
| Options, Fair Value | $ |
$ 0.40
|
$ 1.09
|
|
| Performance Shares, Series 1 |
|
|
|
| Options, rights and restricted stock units granted as share-based payments [Abstract] |
|
|
|
| Number (in shares) | shares |
|
|
116,538
|
| Exercise Price (in dollars per share) |
|
|
$ 0
|
| Vesting Hurdle (30-day VWAP) (weighted average) (in dollars per share) |
|
|
$ 0
|
| Fair Value | $ |
|
|
$ 0.98
|
| Performance Shares, Series 8 |
|
|
|
| Options, rights and restricted stock units granted as share-based payments [Abstract] |
|
|
|
| Number (in shares) | shares |
|
|
388,000
|
| Exercise Price (in dollars per share) |
|
|
$ 0
|
| Vesting Hurdle (30-day VWAP) (weighted average) (in dollars per share) |
|
|
$ 0
|
| Fair Value | $ |
|
|
$ 1.37
|
| Performance Shares, Series 9 |
|
|
|
| Options, rights and restricted stock units granted as share-based payments [Abstract] |
|
|
|
| Number (in shares) | shares |
|
|
50,000
|
| Exercise Price (in dollars per share) |
|
|
$ 0
|
| Vesting Hurdle (30-day VWAP) (weighted average) (in dollars per share) |
|
|
$ 0
|
| Fair Value | $ |
|
|
$ 1.37
|